nach oben

Current Rheumatology Reports

Erschienen in:

01.12.2010

Is It All Central Sensitization? Role of Peripheral Tissue Nociception in Chronic Musculoskeletal Pain

verfasst von: Roland Staud

Erschienen in: Current Rheumatology Reports | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Fibromyalgia syndrome (FM) is a highly prevalent musculoskeletal disorder that is often accompanied by somatic hyperalgesia (enhanced pain from noxious stimuli). Neural mechanisms of somatic hyperalgesia have been analyzed via quantitative sensory testing of FM patients. Results of these studies suggest that FM pain is associated with widespread primary and secondary cutaneous hyperalgesia, which are dynamically maintained by tonic impulse input from deep tissues and likely by brain-to-spinal cord facilitation. Enhanced somatic pains are accompanied by mechanical hyperalgesia and allodynia in FM patients as compared with healthy controls. FM pain is likely to be at least partially maintained by peripheral impulse input from deep tissues. This conclusion is supported by results of several studies showing that injection of local anesthetics into painful muscles normalizes somatic hyperalgesia in FM patients.

Buskila D, Neumann L, Vaisberg G, et al.: Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis Rheum 1997, 40:446–452.CrossRefPubMed

Neumann L, Zeldets V, Bolotin A, et al.: Outcome of posttraumatic fibromyalgia: a 3-year follow-up of 78 cases of cervical spine injuries. Semin Arthritis Rheum 2003, 32:320–325.CrossRefPubMed

Gowans SE, deHueck A, Voss S, et al.: Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care Res 2001, 45:519–529.CrossRef

King SJ, Wessel J, Bhambhani Y, et al.: The effects of exercise and education, individually or combined, in women with fibromyalgia. J Rheumatol 2002, 29:2620–2627.PubMed

Jones KD, Clark SR: Individualizing the exercise prescription for persons with fibromyalgia. Rheum Dis Clin North Am 2002, 28:419–436.CrossRefPubMed

Isomeri R, Mikkelsson M, Latikka P, et al.: Effects of amitriptyline and cardiovascular fitness training on pain in patients with primary fibromyalgia. J Musculoskelet Pain 1993, 2:253–260.CrossRef

Angelopoulos TJ, Denys BG, Weikart C, et al.: Endogenous opioids may modulate catecholamine secretion during high intensity exercise. Eur J Appl Physiol 1995, 70:195–199.CrossRef

Schwarz L, Kindermann W: Changes in beta-endorphin levels in response to aerobic and anaerobic exercise. Sports Med 1992, 13:25–36.CrossRefPubMed

Peng YB, Lin Q, Willis WD: Involvement of alpha-2 adrenoceptors in the periaqueductal gray-induced inhibition of dorsal horn cell activity in rats. J Pharmacol Exp Ther 1996, 278:125–135.PubMed

10.

Cooper BY, Vierck CJ, Yeomans DC: Selective reduction of second pain sensations by systemic morphine in humans. Pain 1986, 24:93–116.CrossRefPubMed

11.

Price DD, Vander-Gruen A, Miller J, et al.: A psychophysical analysis of morphine analgesia. Pain 1985, 22:261–269.CrossRefPubMed

12.

Baker AK, Hoffmann VL, Meert TF: Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay. Acta Anaesthesiol Belg 2002, 53:203–212.PubMed

13.

De Kock M, Meert TF: Alpha 2-adrenoceptor agonists and stress-induced analgesia in rats: influence of stressors and methods of analysis. Pharmacol Biochem Behav 1997, 58:109–117.CrossRefPubMed

14.

King CD, Devine DP, Vierck CJ, et al.: Differential effects of stress on escape and reflex responses to nociceptive thermal stimuli in the rat. Brain Res 2003, 987:214–222.CrossRefPubMed

15.

Owens PC, Smith R: Opioid peptides in blood and cerebrospinal fluid during acute stress. Baillieres Clin Endocrinol Metab 1987, 1:415–437.CrossRefPubMed

16.

Satoh M, Kuraishi Y, Kawamura M: Effects of intrathecal antibodies to substance P, calcitonin gene-related peptide and galanin on repeated cold stress-induced hyperalgesia: comparison with carrageenan-induced hyperalgesia. Pain 1992, 49:273–278.CrossRefPubMed

17.

Vidal C, Jacob JJ: Stress hyperalgesia in rats: an experimental animal model of anxiogenic hyperalgesia in human. Life Sci 1982, 31:1241–1244.CrossRefPubMed

18.

Sigurdsson A, Maixner W: Effects of experimental and clinical noxious counterirritants on pain perception. Pain 1994, 57:265–275.CrossRefPubMed

19.

Maixner W, Fillingim R, Sigurdsson A, et al.: Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain 1998, 76:71–81.CrossRefPubMed

20.

Meiworm L, Jakob E, Walker UA, et al.: Patients with fibromyalgia benefit from aerobic endurance exercise. Clin Rheumatol 2000, 19:253–257.CrossRefPubMed

21.

Wigers SH, Stiles TC, Vogel PA: Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scand J Rheumatol 1996, 25:77–86.CrossRefPubMed

22.

Martin L, Nutting A, MacIntosh BR, et al.: An exercise program in the treatment of fibromyalgia. J Rheumatol 1996, 23:1050–1053.PubMed

23.

Mengshoel AM, Vollestad NK, Forre O: Pain and fatigue induced by exercise in fibromyalgia patients and sedentary healthy subjects. Clin Exp Rheumatol 1995, 13:477–482.PubMed

24.

Miles MP, Clarkson PM: Exercise-induced muscle pain, soreness, and cramps. J Sports Med Phys Fitness 1994, 34:203–216.PubMed

25.

• Staud R, Nagel S, Robinson ME, et al.: Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo controlled trial. Pain 2009, 145:96–104. Lidocaine injections increased local pain thresholds and decreased remote secondary heat hyperalgesia in FM patients, emphasizing the important role of peripheral impulse input in maintaining central sensitization in this chronic pain syndrome, which is similar to that of other persistent pain conditions (eg, IBS and CRPS).CrossRefPubMed

26.

Staud R, Robinson ME, Price DD: Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients. J Pain 2007, 8:893–901.CrossRefPubMed

27.

Staud R, Craggs JG, Perlstein WM, et al.: Brain activity associated with slow temporal summation of C-fiber evoked pain in fibromyalgia patients and healthy controls. Eur J Pain 2008, 12:1078–1089.CrossRefPubMed

28.

Staud R, Spaeth M: Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia. CNS Spectr 2008, 13:12–17.PubMed

29.

Hayes SC: Single case experimental design and empirical clinical practice. J Consult Clin Psychol 1981, 49:193–211.CrossRefPubMed

30.

•• Staud R, Robinson ME, Weyl EE, Price DD: Pain variability in fibromyalgia is related to activity and rest: role of peripheral tissue impulse input. J Pain 2010 May 6 (Epub ahead of print). In this study, alternating strenuous exercise with brief rest periods not only decreased overall clinical pain among FM patients but also their mechanical hyperalgesia. No prolonged worsening of overall FM pain and hyperalgesia occurred despite vigorous muscle activity. These findings contribute further evidence that FM pain and hyperalgesia are at least partially maintained by muscle impulse input, and that some types of exercises may be beneficial for FM.

31.

Maquet D, Croisier JL, Renard C, et al.: Muscle performance in patients with fibromyalgia. Joint Bone Spine 2002, 69:293–299.CrossRefPubMed

32.

• Price DD, Craggs JG, Zhou QQ, et al.: Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input and placebo/nocebo factors: evidence from human psychophysics, animal models, and neuroimaging. Neuroimage 2009, 47:995–1001. Enhanced visceral and somatic pains are accompanied by enhanced pain-related brain activity in IBS patients as compared with healthy control participants. That pain in IBS is likely to be at least partially maintained by peripheral impulse input from the colon/rectum is supported by results showing that local rectal-colonic anesthesia normalizes visceral and somatic hyperalgesia in IBS patients and visceral and somatic hypersensitivity in “IBS-like” rats.CrossRefPubMed

33.

Gracely RH, Lynch SA, Bennett GJ: Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 1992, 51:175–194.CrossRefPubMed

34.

McCain GA, Bell DA, Mai FM, et al.: A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum 1988, 31:1135–1141.CrossRefPubMed

35.

van Santen M, Bolwijn P, Landewe R, et al.: High or low intensity aerobic fitness training in fibromyalgia: Does it matter? J Rheumatol 2002, 29:582–587.PubMed

36.

Norregaard J, Lykkegaard JJ, Mehlsen J, et al.: Exercise training in treatment of fibromyalgia. J Musculoskelet Pain 1997, 5:71–79.CrossRef

37.

Hadhazy VA, Ezzo J, Creamer P, et al.: Mind and body therapy for fibromyalgia. A systematic review. J Rheumatol 2000, 27:2911–2918.PubMed

38.

Rossy LA, Buckelew SP, Dorr N, et al.: A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med 1999, 21:180–191.CrossRefPubMed

39.

Busch AJ, Schachter CL, Overend TJ, et al.: Exercise for treating fibromyalgia: a systematic review. J Rheumatol 2008, 35:1130–1144.PubMed

40.

Busch A, Barber KAR, Overend TJ, et al.: Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev 2007, 4:CD003786.PubMed

41.

Wolfe F, Smythe HA, Yunus MB, et al.: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160–172.CrossRefPubMed

42.

Wolfe F, Clauw DJ, Fitzcharles MA, et al.: The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010, 62:600–610.CrossRef

43.

Gerwin RD: Differential diagnosis of myofascial pain syndrome and fibromyalgia. J Musculoskelet Pain 1999, 7:209–215.CrossRef

44.

Harden RN: Muscle pain syndromes. Am J Phys Med Rehabil 2007, 86(1 Suppl):S47–S58.CrossRef

45.

Pearce JMS: Myofascial pain, fibromyalgia or fibrositis? Eur Neurol 2004, 52:67–72.CrossRefPubMed

46.

Alvarez DJ, Rockwell PG: Trigger points: diagnosis and management. Am Fam Physician 2002, 65:653–660.PubMed

47.

Wang YH, Ding XL, Zhang Y, et al.: The predetermined sites of examination for tender points in fibromyalgia syndrome are frequently associated with myofascial trigger points. J Pain 2010, 11:644–651.CrossRefPubMed

48.

Bergman S, Herrstrom P, Jacobsson LTH, et al.: Chronic widespread pain: a three year followup of pain distribution and risk factors. J Rheumatol 2002, 29:818–825.PubMed

49.

Forseth KO, Husby G, Gran JT, et al.: Prognostic factors for the development of fibromyalgia in women with self-reported musculoskeletal pain. A prospective study. J Rheumatol 1999, 26:2458–2467.PubMed

50.

Papageorgiou AC, Silman AJ, Macfarlane GJ: Chronic widespread pain in the population: a seven year follow up study. Ann Rheum Dis 2002, 61:1071–1074.CrossRefPubMed

51.

Holm LW, Carroll LJ, Cassidy JD, et al.: Widespread pain following whiplash-associated disorders: incidence, course, and risk factors. J Rheumatol 2007, 34:193–200.PubMed

52.

Andersson HI: The course of non-malignant chronic pain: a 12-year follow-up of a cohort from the general population. Eur J Pain 2004, 8:47–53.CrossRefPubMed

53.

Wynne-Jones G, Jones GT, Wiles NJ, et al.: Predicting new onset of widespread pain following a motor vehicle collision. J Rheumatol 2006, 33:968–974.PubMed

54.

Holm LW, Carroll LJ, Cassidy D, et al.: Factors influencing neck pain intensity in whiplash-associated disorders in Sweden. Clin J Pain 2007, 23:591–597.CrossRefPubMed

55.

McBeth J, Macfarlane GJ, Benjamin S, et al.: Features of somatization predict the onset of chronic widespread pain: results of a large population-based study. Arthritis Rheum 2001, 44:940–946.CrossRefPubMed

56.

Lapossy E, Maleitzke R, Hrycaj P, et al.: The frequency of transition of chronic low back pain to fibromyalgia. Scand J Rheumatol 1995, 24:29–33.CrossRefPubMed

57.

Price DD, Bennett GJ, Rafii A: Psychophysical observations on patients with neuropathic pain relieved by a sympathetic block. Pain 1989, 36:273–288.CrossRefPubMed

58.

Price DD, Long S, Wilsey B, et al.: Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional pain syndrome patients. Clin J Pain 1998, 14:216–226.CrossRefPubMed

59.

Scholz A: Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels. Br J Anaesth 2002, 89:52–61.CrossRefPubMed

60.

Devor M: Sodium channels and mechanisms of neuropathic pain. J Pain 2006, 7(1 Suppl 1):S3–S12.CrossRefPubMed

61.

Verne GN, Robinson ME, Vase L, et al.: Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain 2003, 105:223–230.CrossRefPubMed

62.

Verne GN, Sen A, Price DD: Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome. J Pain 2005, 6:493–496.CrossRefPubMed

63.

• Zhou Q, Fillingim RB, Riley JL, et al.: Central and peripheral hypersensitivity in the irritable bowel syndrome. Pain 2010, 148:454–461. The somatic hypersensitivity in IBS patients was somatotopically organized in that the lower extremities demonstrated the greatest hypersensitivity. The results of this study suggest that a more widespread alteration in central pain processing in a subset of IBS patients may be present, as they display hypersensitivity to heat, ischemic, and cold pressor stimuli.CrossRefPubMed

64.

Al-Chaer ED, Kawasaki M, Pasricha PJ: A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 2000, 119:1276–1285.CrossRefPubMed

65.

Lin C, Al-Chaer ED: Long-term sensitization of primary afferents in adult rats exposed to neonatal colon pain. Brain Res 2003, 971:73–82.CrossRefPubMed

66.

Zhou Q, Price DD, Caudle RM, et al.: Visceral and somatic hypersensitivity in TNBS-induced colitis in rats. Dig Dis Sci 2007, 53:429–435.CrossRefPubMed

67.

Zhou Q, Price DD, Caudle RM, et al.: Visceral and somatic hypersensitivity in a subset of rats following TNBS-induced colitis. Pain 2008, 134:9–15.CrossRefPubMed

68.

Zhou Q, Price DD, Verne GN: Reversal of visceral and somatic hypersensitivity in a subset of hypersensitive rats by intracolonic lidocaine. Pain 2008, 139:218–224.CrossRefPubMed

69.

Verne GN, Robinson ME, Price DD: Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain 2001, 93:7–14.CrossRefPubMed

70.

Russell IJ, Orr MD, Littman B, et al.: Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994, 37:1593–1601.CrossRefPubMed

71.

Sorensen J, Bengtsson A, Ahlner J, et al.: Fibromyalgia—are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 1997, 24:1615–1621.PubMed

72.

Sorensen J, Graven-Nielsen T, Henriksson KG, et al.: Hyperexcitability in fibromyalgia. J Rheumatol 1998, 25:152–155.PubMed

73.

Graven-Nielsen T, Aspegren KS, Henriksson KG, et al.: Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 2000, 85:483–491.CrossRefPubMed

74.

Staud R, Vierck CJ, Cannon RL, et al.: Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001, 91:165–175.CrossRefPubMed

75.

Berglund B, Harju EL, Kosek E, et al.: Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain 2002, 96:177–187.CrossRefPubMed

76.

Granot M, Buskila D, Granovsky Y, et al.: Simultaneous recording of late and ultra-late pain evoked potentials in fibromyalgia. Clin Neurophysiol 2001, 112:1881–1887.CrossRefPubMed

77.

Lorenz J, Grasedyck K, Bromm B: Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome. Electroencephalogr Clin Neurophysiol 1996, 100:165–168.CrossRefPubMed

78.

Lautenbacher S, Rollman GB: Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 1997, 13:189–196.CrossRefPubMed

79.

Yunus MB: Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol 1992, 19:846–850.PubMed

80.

Granges G, Littlejohn G: Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 1993, 36:642–646.CrossRefPubMed

81.

Desmeules JA, Cedraschi C, Rapiti E, et al.: Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 2003, 48:1420–1429.CrossRefPubMed

82.

Staud R, Price DD, Robinson ME, et al.: Maintenance of windup of second pain requires less frequent stimulation in fibromyalgia patients compared to normal controls. Pain 2004, 110:689–696.CrossRefPubMed

83.

Arendt-Nielsen L, Graven-Nielsen T: Central sensitization in fibromyalgia and other musculoskeletal disorders. Curr Pain Headache Rep 2003, 7:355–361.CrossRefPubMed

84.

Gracely RH, Petzke F, Wolf JM, et al.: Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002, 46:1333–1343.CrossRefPubMed

85.

Cook DB, Lange G, Ciccone DS, et al.: Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 2004, 31:364–378.PubMed

86.

87.

Kong J, White NS, Kwong KK, et al.: Using fMRI to dissociate sensory encoding from cognitive evaluation of heat pain intensity. Hum Brain Mapp 2006, 27:715–721.CrossRefPubMed

88.

Gebhart GF: Descending modulation of pain. Neurosci Biobehav Rev 2004, 27:729–737.CrossRefPubMed

89.

Porreca F, Ossipov MH, Gebhart GF: Chronic pain and medullary descending facilitation. Trends Neurosci 2002, 25:319–325.CrossRefPubMed

90.

Staud R, Robinson ME, Vierck CJ, et al.: Ratings of experimental pain and pain-related negative affect predict clinical pain in patients with fibromyalgia syndrome. Pain 2003, 105:215–222.CrossRefPubMed

91.

Staud R, Price DD, Robinson ME, et al.: Body pain area and pain-related negative affect predict clinical pain intensity in patients with fibromyalgia. J Pain 2004, 5:338–343.CrossRefPubMed

92.

Staud R, Vierck CJ, Robinson ME, et al.: Overall fibromyalgia pain is predicted by ratings of local pain and pain related negative affect: possible role of peripheral tissues. Rheumatology 2006, 45:1409–1415.CrossRefPubMed

Titel: Is It All Central Sensitization? Role of Peripheral Tissue Nociception in Chronic Musculoskeletal Pain
verfasst von: Roland Staud
Publikationsdatum: 01.12.2010
Verlag: Current Science Inc.
Erschienen in: Current Rheumatology Reports / Ausgabe 6/2010
Print ISSN: 1523-3774
Elektronische ISSN: 1534-6307
DOI: https://doi.org/10.1007/s11926-010-0134-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Is It All Central Sensitization? Role of Peripheral Tissue Nociception in Chronic Musculoskeletal Pain

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2010

The Role of Quantitative Sensory Testing in the Evaluation of Musculoskeletal Pain Conditions

Rheumatoid Vasculitis: Vanishing Menace or Target for New Treatments?

Is Rituximab Superior to Cyclophosphamide for ANCA-Associated Vasculitis for Induction of Remission, and with a Better Safety Profile?

Pulmonary Vasculitis: Clinical Presentation, Differential Diagnosis, and Management

Pathophysiology of ANCA-Associated Small Vessel Vasculitis

Behçet’s Syndrome

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin